New Patient-Administered Hemoglobin A1c Test

Author: Monica Preboth
Date: Oct 1, 2000

A new test kit for monitoring levels of glycosylated hemoglobin (HbA1c) may make testing easier for patients with diabetes. The BioSafe HbA1c test kit allows patients to collect their own blood sample for laboratory analysis and physician interpretation. The test uses a proprietary method of re-hydrating dried blood samples to produce readings as accurate as tests conducted with liquid samples, according to the manufacturer.

Patients use the kit's finger lancet to collect blood while routinely checking their blood glucose levels. After three drops of blood are put on a collection card, the patient drops the card into a specially sealed packet and mails it in the postage-paid envelope to the BioSafe laboratory for analysis. The results of the test are forwarded to the patient's physician, who interprets the results and adjusts treatment protocols accordingly.

The manufacturer of the test kit cites recommendations of the American Diabetes Association that anyone with diabetes have an HbA1c test at least twice a year. According to the manufacturer, the majority of persons with diabetes are not using HbA1c testing, which is one of the best ways to determine overall blood glucose control. The manufacturer believes that the BioSafe HbA1c test kit will make testing more convenient and patients more compliant. The cost of the kit is covered by most insurance plans.

For more information on the BioSafe HbA1c test kit, visit the BioSafe Web site at http://www. ebiosafe.com.

COPYRIGHT 2000 American Academy of Family PhysiciansCOPYRIGHT 2000 Gale Group

 
© 2006, DrPlace.com, All Rights Reserved.